... Leiomyosarcoma is an aggressive small cell muscle tissue cancer only found in women that usually starts in the area of the uterus.
“My doctor said it was treatable, but not curable,” Lader said, “which means I will have periods of remission and recurrence.”
She tried four kinds of chemotherapy, but none worked. Through the connections of her oncologist at McCullough Hyde Memorial Hospital in Oxford, she entered into a trial for Yondelis, an anti-tumor drug that has been used in Europe and Russia for over 25 years but hasn’t met FDA approval in the U.S. One good thing about the treatments is that they have no side effects, she said.
Every three weeks, she drives to Louisville, Ky., for treatments on Friday, then comes back to work on Monday morning.
And, she said, being able to live a normal life has been crucial to keeping an optimistic outlook.
“I’ve been extremely blessed,” she said. “That’s all I can say.”
PharmaMar Recibe el Ok de la FDA Para Iniciar Fase I con PM54 en Combi con Inmuno Para Posible Tratamiento . PARA EI RELEVO DE LURBINECTEDIN ESTABAN PM184 Y PM14 AMBOS RETIRADOS POR LA CIA. AHORA HAY OTROS DOS FÁRMACOS EN FASE I EN EL INTENTO DE RELEVAR A LURBINECTEDIN : PM54 Y PM534 ... EL PROBLEMA ES QUE AMBOS AÚN ESTAN EN FASE I CON TODO LO QUE ESTO IMPLICA EN CUESTIÓN DE PLAZOS ... YA QUE PARA REALUZAR 3 FASES CLÍNICAS HACEN FALTA DE 12 A 15 AÑOS ... NOS IRÍAMOS AL 2040.
09 abril 2011
El abuso del alcohol es responsable directo de 15.600 tumores al año .
La bebida está ligada con hasta siete tipos de cáncer - El consumo máximo recomendado son dos copas de vino al día en hombres, la mitad en mujeres .
...
...
Suscribirse a:
Comentarios (Atom)